Grünenthal is a finished-dose manufacturer based in Peru. It holds 2 valid CEPs across a filed portfolio of 2 molecules. Its filings concentrate with AIFA (IT), INFARMED (PT) and EMA. Its GMP standing is certified by ANVISA (Brazil).
| Site | FDA FEI |
|---|---|
| Aachen, United Arab Emirates | Not on file |
| AACHEN, Germany | Not on file |
| Aachen, Germany | Not on file |
| SAN BORJA, Peru | Not on file |
| SAN BORJA, Peru | Not on file |
| SAN BORJA, Peru | Not on file |
5 further sites are on record.
| Molecule | Regulators | Docs |
|---|---|---|
| Betahistine Dihydrochloride | EDQM | 1 |
| Tapentadol | EDQM | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| AIFA (IT) | 724 | None |
| INFARMED (PT) | 146 | None |
| EMA | 104 | None |
| MHRA (UK) | 102 | None |
| MPA (SE) | 91 | None |
| FAMHP (BE) | 76 | None |
| ANVISA (Brazil) | None | 4 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2024 | $220.0B | Not reported | Not reported |
| 2023 | $230.0B | Not reported | Not reported |
| 2022 | $170.0B | Not reported | Not reported |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Grünenthal comes back tiered against every other supplier able to file there.
Start for free